DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES
Abstract
Authors
J Chang F Sun H Li